Institutional investors control 14.23% of the outstanding shares in SYN. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended September 2017, these large investors purchased a net $1.2 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WILLIAM BLAIR & CO. LLC (INVESTM... Bought 1.7 Million shares of Synthetic Biologics Inc
683 CAPITAL MANAGEMENT LLC Bought 1.5 Million shares of Synthetic Biologics Inc